Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director CC transcript Auditor change
|
Acorda Therapeutics, Inc. (ACOR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/04/2023 |
4
| COHEN RON (President and CEO) has filed a Form 4 on Acorda Therapeutics, Inc.
Txns:
| Granted 168,800 options to buy
@ $0.586, valued at
$98.9k
|
|
04/04/2023 |
4
| Clem Kerry M (Chief Commercial Officer) has filed a Form 4 on Acorda Therapeutics, Inc.
Txns:
| Granted 77,300 options to buy
@ $0.586, valued at
$45.3k
|
|
04/04/2023 |
4
| Belloff Neil S. (General Counsel and Corp Secy) has filed a Form 4 on Acorda Therapeutics, Inc.
Txns:
| Granted 77,300 options to buy
@ $0.586, valued at
$45.3k
|
|
03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2023 |
4
| Varian John (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 4,712 options to buy
@ $0.7667, valued at
$3.6k
|
|
09/07/2022 |
4
| Sabella Lauren M (COO) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Paid exercise price by delivering 1,511 shares
@ $0.398, valued at
$601.4 |
|
09/07/2022 |
4
| Clem Kerry M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Paid exercise price by delivering 1,511 shares
@ $0.398, valued at
$601.4 |
|
06/14/2022 |
4
| Randall Lorin (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $0.3699, valued at
$3.7k
|
|
06/14/2022 |
4
| PANEM SANDRA PHD (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $0.3699, valued at
$3.7k
|
|
06/14/2022 |
4
| Kelley John P (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $0.3699, valued at
$3.7k
|
|
06/14/2022 |
4
| Jensen Peder (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $0.3699, valued at
$3.7k
|
|
03/21/2022 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Sold 2,289 shares
@ $1.7014, valued at
$3.9k
|
|
01/04/2022 |
4
| Varian John (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 20,000 options to buy
@ $2.39, valued at
$47.8k
|
|
11/09/2021 |
4
| Gesser Michael A (CFO) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 85,000 options to buy
@ $3.74, valued at
$317.9k
|
|
11/09/2021 |
4
| Belloff Neil S. (General Counsel) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 85,000 options to buy
@ $3.74, valued at
$317.9k
|
|
09/08/2021 |
4
| Sabella Lauren M (Chief Commercial Officer) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Paid exercise price by delivering 1,511 shares
@ $4.38, valued at
$6.6k
|
|
09/08/2021 |
4
| Morales Robert (Interim PAO & PFO) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Paid exercise price by delivering 448 shares
@ $4.38, valued at
$2k
|
|
09/08/2021 |
4
| COHEN RON (President and CEO) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Paid exercise price by delivering 3,940 shares
@ $4.38, valued at
$17.3k
|
|
06/04/2021 |
4
| STRADER CATHERINE D. (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $3.75, valued at
$37.5k
|
|
06/04/2021 |
4
| Randall Lorin (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $3.75, valued at
$37.5k
|
|
06/04/2021 |
4
| PANEM SANDRA PHD (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $3.75, valued at
$37.5k
|
|
06/04/2021 |
4
| Kelley John P (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $3.75, valued at
$37.5k
|
|
06/04/2021 |
4
| Jensen Peder (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $3.75, valued at
$37.5k
|
|
06/04/2021 |
4
| Greene Barry E (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 10,000 options to buy
@ $3.75, valued at
$37.5k
|
|
03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/03/2020 |
4
| LAWRENCE DAVID (Chief, Bus. Ops & PAO) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Paid exercise price by delivering 1,141 shares
@ $0.6464, valued at
$737.5 |
|
11/12/2020 |
4
| LAWRENCE DAVID (Chief, Bus. Ops & PAO) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Paid exercise price by delivering 1,024 shares
@ $0.8599, valued at
$880.5 |
|
09/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2020 |
4
| RAUSCHER STEVEN M (Director) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns:
| Granted 15,000 options to buy
@ $0.8512, valued at
$12.8k
|
|
|
|
|